PT. KalGen DNA

medical devices

About

PT. KalGen DNA is a biotechnology company established in 2012 through a partnership between PT Bifarma Adiluhung and DNA Laboratories Sdn. Bhd. The company specializes in developing and marketing molecular diagnostic kits aimed at enhancing human health and personalized healthcare. Key products include the Elva Diagnostic SARS-CoV-2 Real-time RT-PCR Kit for detecting COVID-19 and the INDIGEN MTB/NTM/DR-TB Real Time PCR Kit Gen. 2 for diagnosing tuberculosis and drug resistance. PT. KalGen DNA emphasizes quality and innovation, supported by certifications such as WHO LabNet proficiency and ISO 13485. The company collaborates with laboratories to promote cervical cancer screening, reflecting its commitment to preventive healthcare. PT. KalGen DNA serves healthcare providers, diagnostic laboratories, and public health programs in Indonesia, focusing on infectious disease detection and genetic screening. The company imports essential materials from Malaysia and the United States and exports its diagnostic products, leveraging strategic partnerships to enhance its supply chain.

Technologies

OutlookMicrosoft Office 365Amazon AWSMobile FriendlyGoogle Font API

Keywords

cervical cancer screening & hpv testhpv testcervical cancer screeningdiagnostic kitcovid19 screeningmedical equipment manufacturingnucleic acid amplificationservicesdiagnostic manufacturinghpv genotypingoncology diagnosticsreal-time pcrhealthcare equipment & supplies manufacturingt790m mutation detectionnucleic acid amplification technologymutation detectionhpv 16/18 detectionmedical equipment and supplies manufacturinghealthcare technologysars-cov-2 testingb2bin-vitro diagnosticsmedical diagnosticshigh-risk hpv detectiontb detectionpcr kitscovid-19 testinggenotyping kitsmutation analysismedical laboratories

Location

23 Jalan Pulogadung, Jakarta, Special Capital Region of Jakarta, Indonesia, 13240

Related Companies

Companies in the same industry